Last reviewed · How we verify

Sucrose Placebo (water)

The Hospital for Sick Children · Phase 3 active Small molecule

Sucrose Placebo (water) is a Small molecule drug developed by The Hospital for Sick Children. It is currently in Phase 3 development.

Sucrose Placebo (water) has no known mechanism of action.

At a glance

Generic nameSucrose Placebo (water)
SponsorThe Hospital for Sick Children
ModalitySmall molecule
PhasePhase 3

Mechanism of action

As a placebo, Sucrose Placebo (water) does not have a pharmacological effect. It is used as a control in clinical trials to compare the efficacy of active treatments.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Sucrose Placebo (water)

What is Sucrose Placebo (water)?

Sucrose Placebo (water) is a Small molecule drug developed by The Hospital for Sick Children.

How does Sucrose Placebo (water) work?

Sucrose Placebo (water) has no known mechanism of action.

Who makes Sucrose Placebo (water)?

Sucrose Placebo (water) is developed by The Hospital for Sick Children (see full The Hospital for Sick Children pipeline at /company/the-hospital-for-sick-children).

What development phase is Sucrose Placebo (water) in?

Sucrose Placebo (water) is in Phase 3.

Related